Engagement of collagen-binding integrins promotes matrix metalloproteinase-9-dependent E-cadherin ectodomain shedding in ovarian carcinoma cells

Cancer Research

Volumn 67, Issue 5, 2007, Pages 2030-2039

  Symowicz, Jaime ^a   Adley, Brian P ^a   Gleason, Kara J ^a   Johnson, Jeffrey J ^a   Ghosh, Supurna ^a   Fishman, David A ^b   Hudson, Laurie G ^c   Stack, M Sharon ^a,d  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NEW YORK UNIVERSITY   (United States)

^c UNIVERSITY OF NEW MEXICO   (United States)

^d University of Missouri   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; GELATINASE B; INTEGRIN; PROTEIN TYROSINE KINASE; UVOMORULIN;

ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; HUMAN; HUMAN CELL; METASTASIS; OVARY CARCINOMA; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN EXPRESSION;

ADHERENS JUNCTIONS; CADHERINS; CARCINOMA; CELL-MATRIX JUNCTIONS; COLLAGEN; FEMALE; HUMANS; INTEGRINS; MATRIX METALLOPROTEINASE 9; NEOPLASM INVASIVENESS; OVARIAN NEOPLASMS; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN STRUCTURE, TERTIARY; TUMOR CELLS, CULTURED;

EID: 33947219432     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-06-2808     Document Type: Article

References (55)

1. Fishman D, Borzorgi K. The scientific basis of early detection of epithelial ovarian cancer: the national ovarian cancer early detection program (NOCEDP). In: Stack MS, Fishman DA, editors. Cancer treatment and research: ovarian cancer. Boston: Kluwer Academic Publishers; 2002. p. 3-28.
2. Naora H, Montell DJ. Ovarian cancer metastasis: integrating insights from disparate model organisms. Nat Rev Cancer 2005;5:355-66.
3. Ghosh S, Wu Y, Stack MS. Ovarian Cancer-associated proteinases. In: Stack MS, Fishman DA, editors. Cancer treatment and research: ovarian cancer. Boston: Kluwer Academic Publishers; 2002. p. 331-54.
4. Offner FA, Obrist P, Stadlmann S, et al. IL-6 secretion by human peritoneal mesothelial and ovarian cancer cells. Cytokine 1995;7:542-7.
5. Mutsaers SE. Mesothelial cells: their structure, function, and role in serosal repair. Respirology 2002;7:171-91.
6. Freedman RS, Deavers M, Liu J, Wang E. Peritoneal inflammation: a microenvironment for epithelial ovarian cancer (EOC). J Transl Med 2004;2:23.
7. Auersperg N, Pan J, Grove BD, et al. E-cadherin induces mesenchymal-to-epithelial transition in human ovarian surface epithelium. Proc Natl Acad Sci U S A 1999;96:6249-54.
8. Wong AST, Maines-Bandiera SL, Rosen B, et al. Constitutive and conditional cadherin expression in cultured human ovarian surface epithelium: influence of family history of ovarian cancer. Int J Cancer 1999;81:180-8.
9. Maines-Bandiera SL, Auersperg N. Increased E-cadherin expression in ovarian surface epithelium: an early step in metaplasia and dysplasia? Int J Gynecol Pathol 1997;16:250-5.
10. Imai T, Horiuchi A, Shiozawa T, et al. Elevated expression of E-cadherin and α-, β, and γ-catenins in metastatic lesions compared with primary epithelial ovarian carcinomas. Hum Pathol 2004;35:1469-76.
11. Wong AST, Auersperg N. Normal ovarian surface epithelium. In: Stack MS, Fishman DA, editors. Cancer treatment and research: ovarian cancer. Boston: Kluwer Academic Publishers; 2002. p. 161-84.
12. Sundfeldt K, Ivarsson K, Rask K, et al. Higher levels of soluble E-cadherin in cyst fluid from malignant ovarian tumours than in benign cysts. Anticancer Res 2001;21:65-70.
13. Darai E, Bringuier AF, Walker-Combrouze F, Feldmann G, Madelenat P, Scoazec, JY. Soluble adhesion molecules in serum and cyst fluid from patients with cystic tumours of the ovary. Hum Reprod 1998;13:2831-5.
14. Yamada KM, Miyamoto S. Integrin transmembrane signaling and cytoskeletal control. Curr Opin Cell Biol 1995;7:681-9.
15. 1 integrin. Cancer Res 1999;59:1635-41.
16. Ellerbroek SM, Wu YI, Overall CM, Stack MS. Functional interplay between type I collagen and cell surface matrix metalloproteinase activity. J Biol Chem 2001;276:24833-42.
17. Damsky C, Richa J, Solter D, Knudsen K, Buck C. Identification and purification of a cell surface glycoprotein mediating intercellular adhesion in embryonic and adult tissue. Cell 1983;34:455-66.
18. Lochter A, Galosy S, Muschler J, Freedman N, Werb Z, Bissell MJ. Matrix metalloproteinase stromelysin-1 triggers a cascade of molecular alterations that leads to stable epithelial-to-mesenchymal conversion and a premalignant phenotype in mammary epithelial cells. J Cell Biol 1997;139:1861-72.
19. Noe V, Fingleton B, Jacobs K, et al. Release of an invasion promoter E-cadherin fragment by matrilysin and stromelysin-1. J Cell Sci 2001;114:111-8.
20. Maretzky T, Reiss K, Ludwig A, et al. ADAM10 mediates E-cadherin shedding and regulates epithelial cell-cell adhesion, migration, and β-catenin translocation. Proc Natl Acad Sci U S A 2005;102:9182-7.
21. Covington M, Burghardt R, Parrish A. Ischemia-induced cleavage of cadherins in NRK cells requires MT1-MMP (MMP-14). Am J Physiol Renal Physiol 2006;290:F43-51.
22. Symowicz J, Adley BP, Woo MMM, Auersperg N, Hudson LG, Stack MS. Cyclooxygenase-2 functions as a mediator of lysophosphatidic acid to promote aggressive behavior in ovarian carcinoma cells. Cancer Res 2005;65:2234-42.
23. 1 integrin association in proteinase regulatory pathways. J Biol Chem 2006;281:13021-9.
24. Fridman R, Toth M, Chvyrkova I, Meroueh SO, Mobashery S. Cell surface association of matrix metalloproteinase-9 (gelatinase B). Cancer Metastasis Rev 2003;22:153-66.
25. Niessen CM, Gumbiner BM. Cadherin-mediated cell sorting not determined by binding or adhesion specificity. J Cell Biol 2002;156:389-99.
26. Marques F, Fonsechi-Carvasan GA, De Angelo Andrade LAL, Bottcher-Luiz F. Immunohistochemical patterns for α and β-catenin, E- and N-cadherin expression in ovarian epithelial tumors. Gynecol Oncol 2004;94:16-24.
27. Chan A, Chu KM, Lam SK, et al. Early prediction of tumor recurrence after curative resection of gastric carcinoma by measuring soluble E-cadherin. Cancer 2005;104:740-6.
28. Syrigos KN, Harrington KJ, Karayiannakis AJ, Baibas N, Katirtzoglou N, Roussou P. Circulating soluble E-cadherin levels are of prognostic significance in patients with multiple myeloma. Anticancer Res 2004;24:2027-31.
29. Billion K, Ibrahim H, Mauch C, Niessen CM. Increased soluble E-cadherin in melanoma patients. Skin Pharmacol Physiol 2006;19:65-70.
30. Irby RA, Yeatman TJ. Increased Src activity disrupts cadherin/catenin- mediated homotypic adhesion in human colon cancer and transformed rodent cells. Cancer Res 2002;62:2669-74.
31. Avizienyte E, Wyke A, Jones R, et al. Src-induced deregulation of E-cadherin in colon cancer cells requires integrin signaling. Nat Cell Biol 2002;4:632-38.
32. DeClerck YA. Interactions between tumour cells and stromal cells and proteolytic modification of the extracellular matrix by metalloproteinases in cancer. Eur J Cancer 2000;36:1258-68.
33. Huang LW, Garrett AP, Bell DA, Welch WR, Berkowitz RS, Mok SC. Differential expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 protein and mRNA in epithelial ovarian tumors. Gynecol Oncol 2000;77:369-76.
34. Davidson B, Goldberg I, Gotlieb W, et al. High levels of MMP2, MMP9, MT1-MMP, and TIMP-2 mRNA correlate with poor survival in ovarian carcinoma. Clin Exp Metastasis 1999;17:799-808.
35. Naylor MS, Stamp GW, Davies BD, Balkwill FR. Expression and activity of MMPs and their regulators in ovarian cancer. Int J Cancer 1994;58:50-6.
36. Zhu GG, Risteli J, Puistola U, Kauppila A, Risteli L. Progressive ovarian carcinoma induces synthesis of type I, type III. procollagens in the tumor tissue and peritoneal cavity. Cancer Res 1993;53:5028-32.
37. McCawley LJ, Matrisian LM. Tumor progression: defining the soil around the tumor seed. Curr Biol 2001;11:R25-7.
38. Martin J, Yung S, Robson RL, Steadman R, Davies M. Production and regulation of matrix metalloproteinases and their inhibitors by human peritoneal mesothelial cells. Perit Dial Int 2000;20:524-33.
39. Coussens L, Tinkle C, Hanahan D, Werb Z. MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell 2000;103:481-90.
40. Huang S, Van Arsdall M, Tedjarati S, et al. Contributions of stromal metalloproteinase-9 to angiogenesis and growth of human ovarian carcinoma in mice. J Natl Cancer Inst 2002;94:1134-42.
41. Ozalp S, Tanir HM, Yalcin OT, Kabukcuoglu S, Oner U, Uray M. Prognostic value of matrix metalloproteinase-9 (gelatinase-B) expression in epithelial ovarian tumors. Eur J Gynaecol Oncol 2003;24:417-20.
42. Kamat AA, Fletcher M, Gruman LM, et al. The clinical relevance of stromal matrix metalloproteinase expression in ovarian cancer. Clin Cancer Res 2006;12:1707-14.
43. Lengyel E, Schmalfeldt B, Konik E, et al. Expression of latent matrix metalloproteinase 9 (MMP9) predicts survival in advanced ovarian cancer. Gynecol Oncol 2001;82:291-8.
44. Fishman DA, Bafetti LM, Banionis S, Kearns AS, Chilukuri K, Stack MS. Production of extracellular matrix-degrading proteinases by primary cultures of human epithelial ovarian carcinoma cells. Cancer 1997;80:1457-63.
45. Demeter A, Sziller I, Csapo Z, et al. Molecular prognostic markers in recurrent and in non-recurrent epithelial ovarian cancer. Anticancer Res 2005;25:2885-9.
46. Guo W, Giancotti FG. Integrin signalling during tumour progression. Nat Rev Mol Cell Biol 2004;5:816-26.
47. Arias-Salgado E, Lizano S, Sarkar S, Brugge JS, Ginsberg MH, Shattil SJ. Src kinase activation by direct interaction with the integrin β cytoplasmic domain. Proc Natl Acad Sci U S A 2003;100:13298-302.
48. Ellerbroek SM, Halbleib JM, Benavidez M, et al. Phosphatidylinositol 3-kinase activity in epidermal growth factor-stimulated matrix metalloproteinase-9 production and cell surface association. Cancer Res 2001;61:1855-61.
49. Rathi A, Virmani AK, Schorge JO, et al. Methylation profiles of sporadic ovarian tumors and nonmalignant ovaries from high risk women. Clin Cancer Res 2002;8:3324-31.
50. Makarla P, Saboorian MH, Ashfaq R, et al. Promoter hypermethylation profile of ovarian epithelial neoplasms. Clin Cancer Res 2005;11:5365-9.
51. Dwivedi DJ, Pino G, Banh A, et al. Matrix metalloproteinase inhibitors suppress transforming growth factor-β-induced subcapsular cataract formation. Am J Pathol 2006;168:69-79.
52. Wheelock MJ, Buck CA, Bechtol KB, Damsky CH. Soluble 80-kd fragment of cell-CAM 120/80 disrupts cell-cell adhesion. J Cell Biochem 1987;34:187-202.
53. Nawrocki-Raby B, Gilles C, Polette M, et al. Upregulation of MMPs by soluble E-cadherin in human lung tumor cells. Int J Cancer 2003;105:790-5.
54. Chunthapong J, Seftor E, Khalkhali-Ellis Z, et al. Dual roles of E-cadherin in prostate cancer invasion. J Cell Biochem 2004;91:649-61.
55. Liu WF, Nelson CM, Pirone DM, Chen CS. E-cadherin engagement stimulates proliferation via Rac1. J Cell Biol 2006;173:431-41.